MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Cathcart who wrote (629)	2/2/1998 6:09:00 PM
From: seminole	Read Replies (1) of 1826

David <<<<MGI Pharma is not an easy story to understand>>>> Hey, brokers are not easy to understand. Now, they all like Merck at $120/sh but where were they when it was at $30/sh. Phase II clinical trials should make MGI's story easy to understand. How about Chapter One, patient with tumor; Chapter Two, patient treated in NCI sponsored trails; Chapter Three, tumor stops growing; Chapter Four, no more tumor. This may be too long and complicated. How about a chart with patients tumor size as a liability, growing before treatment and strinking after treatment. We could have a footnote telling them that tumors like liabilities are not good. richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next